BEL116559 Pooled Analysis of Belimumab Elderly Patients

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/50560
• EU PAS number:
  EUPAS42275
• Study ID:
  50560
• Official title and acronym:
  BEL116559 Pooled Analysis of Belimumab Elderly Patients
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  Pooled analyses of elderly subjects (aged ≥ 65 years) who participated in selected belimumab clinical trials
• Study status:
  Ongoing

Research institution and networks

Institutions

GlaxoSmithKline (GSK)

Study timelines

Date when funding contract was signed

Planned: 01/07/2013

Actual: 01/07/2013

Study start date

Planned: 16/06/2013

Actual: 31/05/2013

Date of final study report

Planned: 28/02/2026

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

GlaxoSmithKline

Study protocol

Initial protocol

gsk-116559-reporting-and-analysis-plan-amend1-redact

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)